UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
+$957M |
| 2 |
Microsoft
MSFT
|
+$866M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$692M |
| 4 |
NVIDIA
NVDA
|
+$639M |
| 5 |
Alibaba
BABA
|
+$522M |
Top Sells
| 1 |
Apple
AAPL
|
+$20.3B |
| 2 |
Amazon
AMZN
|
+$10.9B |
| 3 |
Bank of America
BAC
|
+$1.64B |
| 4 |
Applied Materials
AMAT
|
+$1.09B |
| 5 |
Prologis
PLD
|
+$1.03B |
Sector Composition
| 1 | Technology | 29.67% |
| 2 | Financials | 14.84% |
| 3 | Healthcare | 13.16% |
| 4 | Communication Services | 8.88% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Stellar Bancorp
STEL
$1.6B
| $2.39M | ﹤0.01% |
86,535
+15,115
| +21% | +$418K |
|
1902
Coastal Financial
CCB
$1.66B
| $2.39M | ﹤0.01% |
26,465
+1,048
| +4% | +$94.8K |
|
1903
Driven Brands
DRVN
$3.02B
| $2.39M | ﹤0.01% |
139,321
+25,806
| +23% | +$442K |
|
|
EFC
1904
Ellington Financial
EFC
$1.34B
| $2.38M | ﹤0.01% |
179,803
+23,553
| +15% | +$312K |
|
1905
Celldex Therapeutics
CLDX
$1.65B
| $2.38M | ﹤0.01% |
131,296
+14,979
| +13% | +$272K |
|
1906
CareDx
CDNA
$720M
| $2.38M | ﹤0.01% |
133,966
+13,619
| +11% | +$242K |
|
1907
TriMas Corp
TRS
$1.58B
| $2.38M | ﹤0.01% |
101,422
-6,384
| -6% | -$150K |
|
1908
LegalZoom.com
LZ
$1.87B
| $2.38M | ﹤0.01% |
275,978
+4,607
| +2% | +$39.7K |
|
1909
Mesa Laboratories
MLAB
$331M
| $2.37M | ﹤0.01% |
19,977
+685
| +4% | +$81.3K |
|
1910
JELD-WEN Holding
JELD
$541M
| $2.37M | ﹤0.01% |
396,514
+179,615
| +83% | +$1.07M |
|
|
GRAL
1911
GRAIL, Inc. Common Stock
GRAL
$1.35B
| $2.36M | ﹤0.01% |
92,465
+25,177
| +37% | +$643K |
|
1912
Sabre
SABR
$722M
| $2.36M | ﹤0.01% |
839,507
+47,995
| +6% | +$135K |
|
1913
RxSight
RXST
$378M
| $2.36M | ﹤0.01% |
93,382
+8,424
| +10% | +$213K |
|
1914
Vera Therapeutics
VERA
$1.54B
| $2.35M | ﹤0.01% |
98,013
+17,907
| +22% | +$430K |
|
1915
Seaboard Corp
SEB
$3.78B
| $2.35M | ﹤0.01% |
872
+193
| +28% | +$521K |
|
|
AAMI
1916
Acadian Asset Management Inc.
AAMI
$1.73B
| $2.35M | ﹤0.01% |
90,900
+6,501
| +8% | +$168K |
|
1917
Pacira BioSciences
PCRX
$1.21B
| $2.35M | ﹤0.01% |
94,430
-10,425
| -10% | -$259K |
|
1918
Barrett Business Services
BBSI
$1.21B
| $2.35M | ﹤0.01% |
57,003
-10,724
| -16% | -$441K |
|
1919
Revolve Group
RVLV
$1.66B
| $2.34M | ﹤0.01% |
109,066
+10,146
| +10% | +$218K |
|
1920
US Physical Therapy
USPH
$1.24B
| $2.34M | ﹤0.01% |
32,282
-3,479
| -10% | -$252K |
|
1921
Buckle
BKE
$3.09B
| $2.34M | ﹤0.01% |
60,936
-4,085
| -6% | -$157K |
|
1922
Establishment Labs
ESTA
$1.08B
| $2.33M | ﹤0.01% |
57,215
+9,557
| +20% | +$390K |
|
1923
New Fortress Energy
NFE
$376M
| $2.33M | ﹤0.01% |
280,706
+83,279
| +42% | +$692K |
|
1924
DXP Enterprises
DXPE
$1.87B
| $2.33M | ﹤0.01% |
28,320
-4,973
| -15% | -$409K |
|
1925
Century Aluminum
CENX
$2.33B
| $2.3M | ﹤0.01% |
124,001
+21,702
| +21% | +$403K |
|